Login to Your Account

31st Annual J.P. Morgan Healthcare Conference

Light the 'Fusilev' on Success; Spectrum Details Growth Plan

By Randy Osborne
Staff Writer

Thursday, January 10, 2013
During a first-of-the-day session at the J.P. Morgan Healthcare Conference, Spectrum Pharmaceuticals Inc.'s chairman, president and CEO, Rajesh Shrotriya, took on squarely the "much-talked about" matter of boosting Fusilev sales.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription